ACAT-2 Antibodies

Santa Cruz Biotechnology delivers a wide array of ACAT-2 monoclonal antibodies for research focused on acyl-CoA:cholesterol acyltransferase 2 (ACAT-2). ACAT-2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACAT-2 plays a crucial role in lipid metabolism, particularly in the esterification of cholesterol, which is vital for maintaining cellular cholesterol homeostasis. Dysregulation of ACAT-2 has been implicated in several metabolic disorders, making it an important target for research in cardiovascular diseases and atherosclerosis. Understanding ACAT-2 function can provide insights into therapeutic strategies for managing lipid-related diseases. Researchers investigating ACAT-2 can utilize monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Advanced research techniques incorporating ACAT-2 monoclonal antibodies enable detailed analysis of cholesterol metabolism pathways and their impact on cellular function. Santa Cruz Biotechnology monoclonal antibodies for ACAT-2 support researchers worldwide in advancing our understanding of lipid metabolism and its role in human health.